Symbol="RNAZ"
AssetType="Common Stock"
Name="Transcode Therapeutics Inc"
Description="TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic diseases. The company is headquartered in Boston, Massachusetts."
CIK="1829635"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6 LIBERTY SQUARE, #2382, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3314200"
EBITDA="-19982780"
PERatio="None"
PEGRatio="None"
BookValue="-0.299"
DividendPerShare="0"
DividendYield="0"
EPS="-28.69"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-1.028"
ReturnOnEquityTTM="-2.256"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-28.69"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.719"
EVToRevenue="-"
EVToEBITDA="-0.527"
Beta="-0.596"
num_52WeekHigh="31"
num_52WeekLow="1.77"
num_50DayMovingAverage="2.811"
num_200DayMovingAverage="8.32"
SharesOutstanding="1801200"
DividendDate="None"
ExDividendDate="None"
symbol="RNAZ"
open="1.83"
high="1.94"
low="1.81"
price="1.83"
volume="44168.00"
latest_trading_day="2023-08-04"
previous_close="1.83"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="93"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="7"
Volume_recent_avg="543486"
Change_recent_avg="-0.04"
Delta_recent_avg="0.18"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-1.75"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="7"
Aroon_momentum_negative="93"
image_negative_thumbnail_id_1="509"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_negative_thumbnail_id_2="172"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0004.jpeg"
image_neutral_thumbnail_id_1="553"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="959"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_positive_thumbnail_id_2="687"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
